786
Articles
26.8K
Citations
3.3
avg. Impact Factor
72
h-index

Most Cited Articles of Department of Oncology in 2020

TitleJournalYearCitations
Bone health in cancer: ESMO Clinical Practice GuidelinesAnnals of Oncology202082
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines CommitteesEuropean Urology202060
Optimizing the Quality of Colorectal Cancer Screening WorldwideGastroenterology202048
Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening ColonoscopyAnnals of Internal Medicine202028
Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)Lung Cancer202021
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)BJS Open202020
Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [ Pb]Pb-NG001 for prostate cancerJournal of Labelled Compounds and Radiopharmaceuticals202018
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin eraInternational Journal of Cancer202018
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancerInternational Journal of Gynecological Cancer202016
The sacral chordoma marginEuropean Journal of Surgical Oncology202016
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysisActa Oncológica202016
Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironmentMolecular Oncology202012
Sleep quality in hospitalized patients with advanced cancer: an observational study using self-reports of sleep and actigraphySupportive Care in Cancer202012
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver MetastasesClinical Colorectal Cancer202011
Soluble AXL as a marker of disease progression and survival in melanomaPLoS ONE202011
High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal studyEuropean Journal of Oncology Nursing202011
Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activityEBioMedicine202010
Quality indicators in diagnostic upper gastrointestinal endoscopyTherapeutic Advances in Gastroenterology20209
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancerInternational Journal of Cancer20208
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003PLoS ONE20208
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapyMagnetic Resonance Imaging20208
Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastasesCancer Biology and Therapy20208
A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesisMolecular Oncology20208
Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivorsActa Paediatrica, International Journal of Paediatrics20207
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patientsActa Oncológica20207